Status:
UNKNOWN
Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra
Lead Sponsor:
Tata Memorial Hospital
Conditions:
Cervical Cancer
Eligibility:
FEMALE
30-55 years
Phase:
NA
Brief Summary
The study goals are, 1. To determine the test characteristics (sensitivity, specificity, positive predictive value, negative predictive value, false positivity rates, false negativity rates) of healt...
Detailed Description
The three communities, urban slum area in Mumbai, urban non slum area in Mumbai and rural area in Raigad/ Thane district will be selected. The eligible women will be contacted by door to door visit an...
Eligibility Criteria
Inclusion
- Sexually active women in the age group of 30-55 years in the selected areas.
Exclusion
- Pregnant women
- Women having frank cervical cancer
- Women who have undergone total hysterectomy
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT03386695
Start Date
September 1 2018
End Date
January 1 2020
Last Update
August 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012